Valuation (28%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -10.94 | N/A |
PEG Ratio (TTM) | -0.46 | N/A |
P/S Ratio (TTM) | 2.27 | N/A |
P/B Ratio (TTM) | 2.46 | N/A |
P/FCF Ratio (TTM) | 2.20 | N/A |
Price to 5YR AVG Earnings Ratio | -11.42 | N/A |
Price to 5YR AVG FCF Ratio | -6.31 | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -5.10% | N/A |
ROE (TTM) | -27.29% | N/A |
Net Profit Margin (TTM) | -20.68% | N/A |
ROIC 5YR AVG | -39.64% | N/A |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 29.27% | -17,914.32% | -10,856.55% |
Revenue | 9.58% | -2.82% | -14.76% |
Net Income | -156.00% | -18,103.24% | -10,970.31% |
Cash Flow | 12.77% | -485.10% | -278.49% |
Health (47%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 22.26 | N/A |
Quick Ratio (TTM) | 22.26 | N/A |
D/E Ratio (TTM) | 0.57 | N/A |
Interest Coverage (TTM) | 6.18 | N/A |
Piotroski F-Score | 4 | N/A |
Altman Z-Score | 0.94 | N/A |
LTL to 5YR AVG FCF | -1.47 | N/A |
Shares Outstanding Growth 5YR AVG | 0.44% | N/A |